MRK as of Nov 1 · 01:11 ET
MRKNYSEPharmaceutical Preparations
Merck & Co., Inc. · Brief
Next report
93 days
Feb 2 · before openest.Q4 FY26
Expected move
No implied move.
2 of 8≥ implied
- avg implied
- ±4.1%
- avg realized
- ±2.5%
Feb 4 '25±4.3%▼−9.07%×2.12
Apr 24 '25±4.8%▲+1.40%×0.29
Jul 29 '25±4.3%▼−1.70%×0.40
Q3 FY25±3.7%▼−0.35%×0.09
Feb 3 '26±4.3%▲+2.18%×0.51
Q1 FY26±3.9%▼−1.60%×0.41
Q2 FY26±4.1%▲+0.18%×0.04
Oct 29 '26±3.4%▲+3.83%×1.11
quarterimplied−10%0+10%realized×
Oct '26±3.4%▲+3.83%×1.11
Q2 FY26±4.1%▲+0.18%×0.04
Q1 FY26±3.9%▼−1.60%×0.41
Feb '26±4.3%▲+2.18%×0.51
Q3 FY25±3.7%▼−0.35%×0.09
Jul '25±4.3%▼−1.70%×0.40
2 older reports
Apr '25±4.8%▲+1.40%×0.29
Feb '25±4.3%▼−9.07%×2.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Feb 2 report · est.—
Linked exposure
MRK report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.